UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract A002: Autologous Tcells transduced with the affinity enhanced NY-ESO-1c259TCR in patients with synovial sarcoma expressing low levels of the NY-ESO-1 antigen

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.A002-A002

2019

Volltextzugriff (PDF)

Abstract A007: Comparison of pretreatment conditioning on efficacy in two cohorts of a pilot study of genetically engineered NY-ESO-1c259T-cells in patients with synovial sarcoma

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.A007-A007

2019

Volltextzugriff (PDF)

Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6–48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine (P2-11.016)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Bayesian analysis of compositional data

Iyengar, Malini Krishnan

1997

Volltextzugriff (PDF)

A Bioequivalence Comparison at Steady State between the Newly Developed Once-Daily Extended Release Tablet Formulation and the Approved Twice-Daily Tablet Formulation of Deutetrabenazine (P2-11.015)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

A Bioequivalence Comparison Between the Once‐Daily Extended‐Release Tablet and the Twice‐Daily Tablet Formulations of Deutetrabenazine at Steady State

Clinical pharmacology in drug development, 2024-03, Vol.13 (3), p.224-232

2024

Volltextzugriff (PDF)

Box-Cox transformations in Bayesian analysis of compositional data

Environmetrics (London, Ont.), 1998-11, Vol.9 (6), p.657-671

1998

Volltextzugriff (PDF)

COMPOSITIONAL TIME SERIES ANALYSIS OF MORTALITY PROPORTIONS

Communications in statistics. Theory and methods, 2001-01, Vol.30 (11), p.2281-2291

2001

Volltextzugriff (PDF)

Controlled-release carvedilol in the treatment of essential hypertension: Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects

The American journal of cardiology, 2006, Vol.98 (7)

2006

Volltextzugriff (PDF)

Controlled-Release Carvedilol in the Treatment of Essential Hypertension

The American journal of cardiology, 2006-10, Vol.98 (7), p.32-38

2006

Volltextzugriff (PDF)

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study

Journal of the cardiometabolic syndrome, 2008, Vol.3 (4), p.211-217

2008

Volltextzugriff (PDF)

Effect of Combining Extended‐Release Carvedilol and Lisinopril in Hypertension: Results of the COSMOS Study

The journal of clinical hypertension (Greenwich, Conn.), 2010-09, Vol.12 (9), p.678-686

2010

Volltextzugriff (PDF)

Effects of ibuprofen (IB), nabumetone (N) and celecoxib (C) on blood pressure (BP) control in hypertensive patients on ACE inhibitors

American journal of hypertension, 2001-11, Vol.14 (4), p.A85-A85

2001

Volltextzugriff (PDF)

Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials

Circulation. Heart failure, 2011-01, Vol.4 (1), p.18-26

2011

Volltextzugriff (PDF)

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder

The journal of clinical psychiatry, 2003-03, Vol.64 (3), p.250-258

2003

Volltextzugriff (PDF)

Importance of blood pressure control in left ventricular mass regression

Journal of the American Society of Hypertension, 2010-11, Vol.4 (6), p.302-310

2010

Volltextzugriff (PDF)

Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

Blood advances, 2019-07, Vol.3 (13), p.2022-2034

2019

Volltextzugriff (PDF)

Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial

The journal of clinical psychiatry, 2009-01, Vol.70 (1), p.46-57

2009

Volltextzugriff (PDF)

Lowering Blood Pressure With β‐Blockers in Combination With Other Renin‐Angiotensin System Blockers in Patients With Hypertension and Type 2 Diabetes: Results From the GEMINI Trial

The journal of clinical hypertension (Greenwich, Conn.), 2007-11, Vol.9 (11), p.842-849

2007

Volltextzugriff (PDF)

Meta-analysis of outcome studies in end-stage renal disease

Kidney international, 2000-01, Vol.57 (S74), p.S28-S38

2000

Volltextzugriff (PDF)

Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2831-2837

2009

Volltextzugriff (PDF)

Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy

Journal of gastroenterology and hepatology, 2015-08, Vol.30 (8), p.1301-1308

2015

Volltextzugriff (PDF)

P-166: Effects of ibuprofen (IB), nabumetone (N) and celecoxib (C) on blood pressure (BP) control in hypertensive patients on ACE inhibitors

American journal of hypertension, 2001-04, Vol.14 (S1), p.85A-85A

2001

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(40)
Dissertationen
(1)

Sprache

Englisch
(41)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Humans
(19)
Female
(17)
Male
(15)
Treatment Outcome
(14)
Middle Aged
(13)
Double-Blind Method
(12)
Adult
(11)
Aged
(10)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Carbazoles - Therapeutic Use
(6)
Carvedilol
(6)
Hypertension - Drug Therapy
(6)
Paroxetine - Therapeutic Use
(6)
Propanolamines - Therapeutic Use
(6)
Adrenergic Beta-Antagonists - Therapeutic Use
(5)
Anxiety Disorders - Drug Therapy
(5)
Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract A002: Autologous Tcells transduced with the affinity enhanced NY-ESO-1c259TCR in patients with synovial sarcoma expressing low levels of the NY-ESO-1 antigen

Abstract A007: Comparison of pretreatment conditioning on efficacy in two cohorts of a pilot study of genetically engineered NY-ESO-1c259T-cells in patients with synovial sarcoma

Assessment of Dose Proportionality of Three Dose Strengths (6 mg, 12 mg and 24 mg) over the Clinical Dose Range (6–48 mg) of the Newly Developed Once-Daily Extended Release Tablet Formulation of Deutetrabenazine (P2-11.016)

Bayesian analysis of compositional data

A Bioequivalence Comparison at Steady State between the Newly Developed Once-Daily Extended Release Tablet Formulation and the Approved Twice-Daily Tablet Formulation of Deutetrabenazine (P2-11.015)

A Bioequivalence Comparison Between the Once‐Daily Extended‐Release Tablet and the Twice‐Daily Tablet Formulations of Deutetrabenazine at Steady State

Box-Cox transformations in Bayesian analysis of compositional data

COMPOSITIONAL TIME SERIES ANALYSIS OF MORTALITY PROPORTIONS

Controlled-release carvedilol in the treatment of essential hypertension: Design of a novel controlled-release formulation of carvedilol: pharmacology and clinical aspects

Controlled-Release Carvedilol in the Treatment of Essential Hypertension

Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study

Effect of Combining Extended‐Release Carvedilol and Lisinopril in Hypertension: Results of the COSMOS Study

Effects of ibuprofen (IB), nabumetone (N) and celecoxib (C) on blood pressure (BP) control in hypertensive patients on ACE inhibitors

Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials

Efficacy and tolerability of paroxetine for the long-term treatment of generalized anxiety disorder

Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial

Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study

Importance of blood pressure control in left ventricular mass regression

Long‐term safety and activity of NY-ESO‐1 SPEAR T cells after autologous stem cell transplant for myeloma

Low doses of controlled-release paroxetine in the treatment of late-life depression: a randomized, placebo-controlled trial

Lowering Blood Pressure With β‐Blockers in Combination With Other Renin‐Angiotensin System Blockers in Patients With Hypertension and Type 2 Diabetes: Results From the GEMINI Trial

Meta-analysis of outcome studies in end-stage renal disease

Newer Antidepressants and Gabapentin for Hot Flashes: An Individual Patient Pooled Analysis

Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy

P-166: Effects of ibuprofen (IB), nabumetone (N) and celecoxib (C) on blood pressure (BP) control in hypertensive patients on ACE inhibitors

Suchergebnisse filtern